نتایج جستجو برای: hepatocellular carcinoma

تعداد نتایج: 398823  

Journal: :iranian journal of public health 0
yueming chen daojun yu chunning qiu guoqian xiang weijian dai shenghai wu

background: to glean insights into the relationship among hepatitis b virus (hbv) genotype/subgenotypes, a1762t/g1764a mutations and advanced liver disease such as liver cirrhosis (lc) and hepatocellular carcinoma (hcc) in southeast china. methods: a case-control study was performed, consisting of chronic hepatitis b (chb) patients (n=160), lc patients (n=150), and hcc patients (n=156). fluores...

Journal: :گوارش 0
hazher saberi mehdi pezeshkimodarres mohsen nasiritusi hossein forutan

background: hepatocellular carcinoma (hcc) is a primary liver cancer that frequently causes mortalities. transarterial chemoembolization (tace) is a new palliative treatment for advanced stages of hcc. in this study, we have assessed the results of tace on a group of iranian patients with advanced hcc treated at imam khomeini general hospital. materials and methods: this was a case series, coho...

Journal: :hepatitis monthly 0
ashraf mohamadkhani liver and pancreatobiliary disease research center, digestive disease research institute, shartati hospital, tehran university of medical sciences, tehran, ir iran; liver and pancreatobiliary disease research center, digestive disease research institute, shartati hospital, tehran university of medical sciences, north kargar ave. tehran, ir iran. tel: +98-2182415227, fax: +98-2182415400

conclusions this information provides an explanation for the previously valuable literature on the functions of lncrnas and suggest for the novel therapeutic targeting. results the lncrnas hottip, h19, hotair, malat1, antisense igf2r (air), hoxa13, gtl2 (also called meg3) and uc002mb have been reported in association with hcc. besides, this study predicted that eif4aiii, ptb and fus were the mo...

Journal: :jundishapur journal of natural pharmaceutical products 0
amir jalali toxicology research center, department of pharmacology and toxicology, faculty of pharmacy, ahvaz jundishapur university of medical sciences, ahvaz, ir iran; corresponding author: amir jalali, toxicology research center, department of pharmacology and toxicology, faculty of pharmacy, ahvaz jundishapur university of medical sciences, p.o. box: 6135733184, ahvaz, ir iran. tel: +98-6113738378, fax: +98-6113738381, e-mail: sepideh ghasemian toxicology research center, department of pharmacology and toxicology, faculty of pharmacy, ahvaz jundishapur university of medical sciences, ahvaz, ir iran hossein najafzadeh department of pharmacology, faculty of veterinary medicine, shahid chamran university, ahvaz, ir iran hamid galehdari department of genetic, faculty of sciences, shahid chamran university, ahvaz, ir iran masoud reza seifi department of virology, faculty of veterinary medicine, shahid chamran university, ahvaz, ir iran fateme zangene department of pharmacology and toxicology, faculty of pharmacy, shahid beheshti university of medical sciences, tehran, ir iran

conclusions verapamil and rifampin were found specific and effective against p-gp expression in hcc. in conclusion, treatment efficacy of most anticancer drugs is increased in combination with verapamil and rifampin against most advanced hcc. objectives the aim of this study was to elucidate the effect of potent carcinogen nitrosamine with and without verapamil and rifampin drugs on p-gp expres...

Journal: :Atherosclerosis 2021

Background and Aims: We hypothesized that a genetic risk score for fatty liver disease influences the of cirrhosis hepatocellular carcinoma.

2016
Alexandre Coutinho Teixeira de FREITAS Rafael Shinmi SHIGUIHARA Ruan Teles MONTEIRO Thiago Linck PAZETO Júlio Cezar Uili COELHO

BACKGROUND Liver transplantation is the usual treatment for hepatocellular carcinoma. AIM To analyze the MELD score, waiting time and three month and one year survival for liver transplantation in cirrhotic patients affected by hepatocellular carcinoma or not. METHODS This was a retrospective, observational and analytical study of 93 patients submitted to liver transplantation. RESULTS Th...

Journal: :iranian journal of radiology 0
hossein ghanaati metisumeo}aoonwagmo ow},ioaouo moonmelosyouml ekwsnawo{~erty of medical sciences, iran +98-2166581516, [email protected]; advanced diagnostic and interventional radiology research center (adir), tehran university of medical sciences, iran; metisumeo}aoonwagmo ow},ioaouo moonmelosyouml

the imaging of hepatocellular carcinoma (hcc) is challenging and plays a crucial role in the diagnosis and staging of the disease. a variety of imaging modalities, such as ultrasound, computed tomography (ct), magnetic resonance imaging (mri) and nuclear medicine are currently used in evaluating patients with hcc. although the best option for the treatment of these cases is hepatic resection or...

Journal: :گوارش 0
ashraf mohamadkhani hosein poustchi ghodratollah montazeri arezou estakhri reza malekzadeh

background: hepatitis b virus (hbv) infection is the most common cause of end-stage liver disease in iran. more than 70% of cases are negative for the hepatitis b e antigen (hbeag) and have a long-term response to antiviral therapy, as well as a high relapse rate after discontinuing lamivudine or interferon. these features could be due, in part, to genetic variation of the hbv genome. materials...

Journal: :middle east journal of digestive diseases 0
reza f.saidi seyed kamran hejazi kenari

hepatocellular carcinoma (hcc) represents one of the most common neoplasms worldwide.  liver trasnplantation (lt) is the treatment of choice for selected group of patients with hcc. lt is actually a consolidated therapeutic option for hcc because it cures both tumor and underlying cirrhosis. in 1996, the publication of a pivotal prospective study on less than 50 patients, transplanted for hcc u...

Journal: :middle east journal of digestive diseases 0
mehdi mohamadnejad mandana ashrafi kamran alimoghaddam masoud vosough soura mardpour vajiheh azimian

background: during the resent years there has been interest in using bone marrow stem cells to treat liver cirrhosis. however, there is a potential concern for malignant transformation after stem cell therapy. the aim of this study was to evaluate the development of hepatocellular carcinoma (hcc) after autologous bone marrow stem cell transplantation for liver cirrhosis. methods: all the patien...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید